Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:37:20 UTC |
---|
Last Updated | 2019-10-01 21:41:37 UTC |
---|
CypComp ID | CC02191 |
---|
Compound Information |
---|
Name | Pioglitazone |
---|
Structure Image | |
---|
InChIKey | HYAFETHFCAUJAY-QGZVFWFLSA-N |
---|
PubChem ID | 29010894 |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | - <1,2;Cleavage;R1>
- <2,H;Hydroxylation;R2>
- <9,H;Hydroxylation;R3>
- <1,H;Oxidation;R4>
| | | | | - <1,2;Cleavage;R1>
- <2,H;Hydroxylation;R2>
- <9,H;Hydroxylation;R3>
- <1,H;Oxidation;R4>
|
|
---|
References | - Jaakkola T, Laitila J, Neuvonen PJ, Backman JT: Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Basic Clin Pharmacol Toxicol. 2006 Jul;99(1):44-51. doi: 10.1111/j.1742-7843.2006.pto_437.x. [PubMed:16867170 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
---|
Download File | CC02191.sdf |
---|